Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
about
Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and CaffeineReactivity to laboratory stress provocation predicts relapse to cocaineThe search for medications to treat stimulant dependenceTDIQ (5,6,7,8-tetrahydro-1,3-dioxolo [4,5-g]isoquinoline): discovery, pharmacological effects, and therapeutic potentialStress modulates illness-course of substance use disorders: a translational review.Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics.Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking.Sex differences in guanfacine effects on drug craving and stress arousal in cocaine-dependent individualsPhenotypic mapping of metabolic profiles using self-organizing maps of high-dimensional mass spectrometry data.The role of stress in addiction relapse.The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals.Cognitive impairment in acute cocaine withdrawal.Involvement of noradrenergic neurotransmission in the stress- but not cocaine-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for β-2 adrenergic receptors.New medications for the treatment of cocaine dependence.Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.Yohimbine administration and cue-reactivity in cocaine-dependent individualsBetaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in ratsChronic stress, drug use, and vulnerability to addiction.A pattern of perseveration in cocaine addiction may reveal neurocognitive processes implicit in the Wisconsin Card Sorting TestDopamine, norepinephrine and serotonin transporter gene deletions differentially alter cocaine-induced taste aversion.Impact of acute guanfacine administration on stress and cue reactivity in cocaine-dependent individuals.Functional connectivity during language processing in acute cocaine withdrawal: a pilot studyPilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trialYohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes.Increased task difficulty results in greater impact of noradrenergic modulation of cognitive flexibility.Norepinephrine signaling through beta-adrenergic receptors is critical for expression of cocaine-induced anxiety.Emerging role for corticotropin releasing factor signaling in the bed nucleus of the stria terminalis at the intersection of stress and reward.New findings on biological factors predicting addiction relapse vulnerability.PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[(11)C]O-methylreboxetine and HRRTResponse to corticotropin-releasing hormone infusion in cocaine-dependent individualsModeling stress and drug craving in the laboratory: implications for addiction treatment development.Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial.Modeling relapse in animals.Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies.Substance use modulates stress reactivity: Behavioral and physiological outcomes.Effects of abstinence from chronic cocaine self-administration on nonhuman primate dorsal and ventral noradrenergic bundle terminal field structures.Psychosocial stress and the duration of cocaine use in non-treatment seeking individuals with cocaine dependence.Pharmacological blockade of alpha2-adrenoceptors induces reinstatement of cocaine-seeking behavior in squirrel monkeys.A paradigm to investigate the self-regulation of cocaine administration in humans.Effects of chronic cocaine self-administration on norepinephrine transporters in the nonhuman primate brain.
P2860
Q24608522-135A5D5A-5EE2-4371-A64F-689862304EC9Q24655024-AA27F971-7E3B-45B1-BC02-29C565B622CBQ24655160-8FD348F8-1743-4825-B253-EDBF8C7123A1Q28260961-03E562FC-BEE2-4637-B873-7B26F5197838Q30433321-F327FBEC-ECCA-4DEA-830B-FB67FFE2EEBAQ30492891-3B2A5902-05AF-4DFA-9FD2-409E338CC1CDQ30501299-7A04F11D-EB03-48B8-BA0E-768B20E1697AQ30576218-6A399746-1D72-47F3-995E-648437D7F53AQ30582747-222A56F6-E83F-44A2-A784-52A8BA3EAEC4Q31132188-C3BE3182-D2D3-4D24-9ADA-49BB573D6E26Q33598487-EC0301AC-E599-4CF5-A365-657500E46BFAQ34049459-8FF64784-20BE-4A3A-8B2C-E93F4DFCFA1BQ34130038-01871731-0792-426C-86BE-B2BA7CEDC054Q34152650-D990E243-8D27-436B-B9F3-6F6AB47F2A0DQ34253787-59436570-E5A6-4125-91A9-F0E347B9D3A4Q34308172-935DED2F-F8E1-411D-A263-5CEF7DE6AB61Q34870846-5EEEC123-F3D0-4CB9-A589-2E6C9274E626Q34875333-C157C58D-96AE-430F-94A8-B25EA907BA0CQ35000555-3FB8E4B0-099B-45A9-8447-E271C1EA967EQ35014407-8AD113C2-87BC-44C6-9505-02CCBCBF0500Q35106990-CF35AA1B-CA00-4EB8-8FB6-CF4E33AB83E3Q35783469-D86FD20D-7A1B-4C59-AD3E-1835DA4CF72EQ35875805-519F5A37-B6E6-4DA5-9F06-B683E32928A3Q36174084-31E8366B-8ABF-46C2-AEB9-EAFB368C070EQ36678739-91FADC5B-13E6-4833-966A-B06F4613CC38Q36688691-A9A25522-DA6E-4A3C-8525-4A4C7D15F88CQ36881952-BC031702-4D28-4DC3-996A-2812580EFBB0Q36908123-CDA22AE4-BE28-410A-B133-9014169A2C1DQ37056138-877417D5-C83C-45B6-822D-E5E375485354Q37227233-40F3D24B-4597-41E8-92CF-5778E5B688F2Q37306081-CFA8C99F-D71F-4659-8171-3ABCFB4C9B37Q37343634-33A87E25-1214-4214-B7F8-FF09A1175FF7Q37474405-3D6860BE-8B1A-4CBD-A054-730B3E09B9F0Q37702350-090EB8C0-E2FA-46B5-BB76-5D02F9A0BB5DQ38747433-CBBF44A5-6619-4871-B658-38390D4A0A48Q40900027-65847AE7-F834-4CD4-AE93-EA6B91E2E26AQ44596377-84947FAA-E81C-4F16-80FA-1D655B7271F9Q44761981-F1382FC4-E285-4E15-A576-C6BF5A40B1B2Q45279117-9FA69F5B-EDCD-4DFD-A9B6-CEDF439C045CQ45288317-C7640426-A9E7-4555-B293-70892339F8FF
P2860
Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
@en
Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
@nl
type
label
Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
@en
Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
@nl
prefLabel
Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
@en
Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
@nl
P2093
P1433
P1476
Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
@en
P2093
Heninger GR
Malison RT
McDougle CJ
Zimmermann RC
P304
P356
10.1001/ARCHPSYC.1994.03950090045007
P407
P577
1994-09-01T00:00:00Z